Christin E. Burd

11.4k total citations · 2 hit papers
58 papers, 6.5k citations indexed

About

Christin E. Burd is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Christin E. Burd has authored 58 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 23 papers in Oncology and 12 papers in Physiology. Recurrent topics in Christin E. Burd's work include Frailty in Older Adults (10 papers), Histone Deacetylase Inhibitors Research (6 papers) and Telomeres, Telomerase, and Senescence (6 papers). Christin E. Burd is often cited by papers focused on Frailty in Older Adults (10 papers), Histone Deacetylase Inhibitors Research (6 papers) and Telomeres, Telomerase, and Senescence (6 papers). Christin E. Burd collaborates with scholars based in United States, United Kingdom and Singapore. Christin E. Burd's co-authors include Norman E. Sharpless, William R. Jeck, Jessica A. Sorrentino, Michael K. Slevin, William F. Marzluff, Kai Wang, Jinze Liu, Hanna K. Sanoff, Yan Liu and Zefeng Wang and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Christin E. Burd

55 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular RNAs are abundant, conserved, and associated with ALU repeats

2012 3.4k citations William R. Jeck, Jessica A. Sorrentino et al. profile →
Expression of Linear and Novel Circular Forms of an INK4/ARF-Associated Non-Coding RNA Correlates with Atherosclerosis Risk

2010 730 citations Christin E. Burd, William R. Jeck et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christin E. Burd United States	22	5.2k	3.8k	813	625	557	58	6.5k
Jessica A. Sorrentino United States	19	4.1k 0.8×	3.1k 0.8×	573 0.7×	657 1.1×	380 0.7×	45	5.3k
Ji‐Fan Hu United States	44	4.6k 0.9×	1.8k 0.5×	875 1.1×	546 0.9×	509 0.9×	145	6.3k
Beatriz G. Gálvez Spain	37	2.7k 0.5×	1.1k 0.3×	803 1.0×	970 1.6×	427 0.8×	83	5.3k
Sanda Maria Creţoiu Romania	30	1.9k 0.4×	972 0.3×	454 0.6×	343 0.5×	412 0.7×	71	3.4k
Petra Leidinger Germany	34	3.4k 0.7×	3.1k 0.8×	280 0.3×	180 0.3×	361 0.6×	76	4.7k
Haruhisa Iguchi Japan	19	4.3k 0.8×	2.9k 0.8×	423 0.5×	280 0.4×	369 0.7×	25	5.3k
Tan A. Ince United States	42	6.2k 1.2×	1.3k 0.3×	585 0.7×	2.3k 3.7×	726 1.3×	73	9.1k
Evan Y. Yu United States	15	2.2k 0.4×	919 0.2×	368 0.5×	467 0.7×	333 0.6×	53	3.2k
Caroline M. Alexander United States	38	2.5k 0.5×	1.0k 0.3×	500 0.6×	1.3k 2.1×	484 0.9×	74	4.9k
Minna U. Kaikkonen Finland	33	4.0k 0.8×	1.5k 0.4×	260 0.3×	388 0.6×	1.0k 1.8×	107	5.5k

Countries citing papers authored by Christin E. Burd

Since Specialization

Citations

This map shows the geographic impact of Christin E. Burd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christin E. Burd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christin E. Burd more than expected).

Fields of papers citing papers by Christin E. Burd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christin E. Burd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christin E. Burd. The network helps show where Christin E. Burd may publish in the future.

Co-authorship network of co-authors of Christin E. Burd

This figure shows the co-authorship network connecting the top 25 collaborators of Christin E. Burd. A scholar is included among the top collaborators of Christin E. Burd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christin E. Burd. Christin E. Burd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosko, Ashley, Mohamed I. Elsaid, Jennifer A. Woyach, et al.. (2024). Determining the relationship of p16INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy. Journal of Cancer Survivorship. 18(4). 1168–1178. 3 indexed citations

Han, Claire J., Ning Xia, Christin E. Burd, et al.. (2024). Chemotoxicity and Associated Risk Factors in Colorectal Cancer: A Systematic Review and Meta-Analysis. Cancers. 16(14). 2597–2597. 9 indexed citations

Rosko, Ashley, Ying Huang, Sarah Wall, et al.. (2024). Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancy. Journal of Geriatric Oncology. 16(1). 102144–102144. 1 indexed citations

Madison, Annelise A., Christin E. Burd, Rebecca Andridge, et al.. (2023). Gut Microbiota Richness and Diversity Track With T Cell Aging in Healthy Adults. The Journals of Gerontology Series A. 79(3). 6 indexed citations

Aguilar‐Valenzuela, Renan, et al.. (2023). The OSUMMER lines: A series of ultraviolet‐accelerated NRAS‐mutant mouse melanoma cell lines syngeneic to C57BL/6. Pigment Cell & Melanoma Research. 36(5). 365–377. 2 indexed citations

Husain, Marium, Rebecca Hoyd, Alexa Meara, et al.. (2023). De-correlating immune checkpoint inhibitor toxicity and response in melanoma via the microbiome.. Journal of Clinical Oncology. 41(16_suppl). 9569–9569. 2 indexed citations

Terrell, Elizabeth M., Venkat R. Chirasani, Min Chen, et al.. (2022). Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation. Nature Communications. 13(1). 3153–3153. 23 indexed citations

Chen, Zhihua, Jiannong Li, Eslam Mohamed, et al.. (2021). Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity. Cancer Immunology Research. 9(5). 554–567. 19 indexed citations

Presley, Carolyn J., Fábio Gomes, Christin E. Burd, Ravindran Kanesvaran, & Melisa L. Wong. (2021). Immunotherapy in Older Adults With Cancer. Journal of Clinical Oncology. 39(19). 2115–2127. 45 indexed citations

10.

Bowman, Robert L., Amy Webb, Krista M. D. La Perle, et al.. (2021). UVB mutagenesis differs in Nras- and Braf-mutant mouse models of melanoma. Life Science Alliance. 4(9). e202101135–e202101135. 13 indexed citations

11.

Pathak, Shilpa, William C. Stewart, Christin E. Burd, Mark E. Hester, & David A. Greenberg. (2020). Brd2 haploinsufficiency extends lifespan and healthspan in C57B6/J mice. PLoS ONE. 15(6). e0234910–e0234910. 6 indexed citations

12.

Kumar, Dileep, Tong Liu, David H. Lum, et al.. (2020). Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo. Journal of Investigative Dermatology. 141(1). 132–141.e3. 18 indexed citations

13.

Burd, Christin E., et al.. (2019). Rapid Generation of Primary Murine Melanocyte and Fibroblast Cultures. Journal of Visualized Experiments. 4 indexed citations

14.

Lucas, Fabienne, Michael L. Pennell, Ying Huang, et al.. (2019). T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma. Biology of Blood and Marrow Transplantation. 26(1). 7–15. 43 indexed citations

15.

Farren, Matthew R., Reena Shakya, Gregory Young, et al.. (2017). The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors. Molecular Cancer Therapeutics. 16(3). 417–427. 23 indexed citations

16.

Guan, Xiangnan, Kyle M. LaPak, Christina Y. Yu, et al.. (2016). Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth. Molecular Cancer Research. 15(3). 237–249. 81 indexed citations

17.

Burd, Christin E., Wenjin Liu, Kelly S. Clark, et al.. (2014). Mutation-Specific RAS Oncogenicity Explains NRAS Codon 61 Selection in Melanoma. Cancer Discovery. 4(12). 1418–1429. 135 indexed citations

18.

Sorrentino, Jessica A., Janakiraman Krishnamurthy, Stephen L. Tilley, et al.. (2013). p16INK4a reporter mice reveal age-promoting effects of environmental toxicants. Journal of Clinical Investigation. 124(1). 169–173. 66 indexed citations

19.

Burd, Christin E., Jessica A. Sorrentino, Kelly S. Clark, et al.. (2013). Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model. Cell. 152(1-2). 340–351. 305 indexed citations

20.

Liu, Yan, Hanna K. Sanoff, Hyunsoon Cho, et al.. (2009). Expression of p16^INK4a in peripheral blood T‐cells is a biomarker of human aging. Aging Cell. 8(4). 439–448. 357 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact